Crisis over shortage of Remdesivir, Fabiflu to end by next fortnight
SECTIONS
Last Updated: May 01, 2021, 12:32 PM IST
Share
Synopsis An unprecedented surge in demand of some crucial medicines, used in treating Covid patients, has created a mess. Now companies like Cipla or Cadila, and others have increased production of vials manifolds. We promise supplies will be sufficient, Rajiv Singhal, General Secretary of All India Organisation of Chemists and Druggists(AIOCD), representing over 9.50 lakh chemists across the country, told IANS.
PTI
Though dire shortages of Covid-19 related medicines, seeing price spikes on the black market, the country s apex chemist body have assured that a sizable increase in supply of important life saving drugs from manufacturing companies would end the crisis by next fortnight in India.
रेमडेसिविर की नहीं होगी किल्लत, टॉप केमिस्ट बॉडी ने जीवन रक्षक दवाओं की जल्द आपूर्ति का दिया आश्वासन
punjabkesari.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from punjabkesari.com Daily Mail and Mail on Sunday newspapers.
Crisis over shortage of Remdesivir, Fabiflu to end by next fortnight
prokerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prokerala.com Daily Mail and Mail on Sunday newspapers.